HAP Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32,509
| Closed | -$1.53M | – | 692 |
|
|
2024
Q2 | $1.35M | Buy |
32,509
+12,441
| +62% | +$557K | 0.16% | 112 |
|
|
2024
Q1 | $1.09M | Buy |
+20,068
| New | +$1.02M | 0.12% | 116 |
|
|
2023
Q3 | – | Sell |
-11,534
| Closed | -$707K | – | 1056 |
|
|
2023
Q2 | $738K | Buy |
+11,534
| New | +$773K | 0.13% | 145 |
|
|
2023
Q1 | – | Sell |
-23,929
| Closed | -$1.69M | – | 1222 |
|
|
2022
Q4 | $1.72M | Sell |
23,929
-31,034
| -56% | -$2.34M | 0.18% | 133 |
|
|
2022
Q3 | $3.91M | Buy |
54,963
+35,788
| +187% | +$2.6M | 0.26% | 90 |
|
|
2022
Q2 | $1.48M | Sell |
19,175
-9,477
| -33% | -$722K | 0.07% | 219 |
|
|
2022
Q1 | $2.09M | Buy |
28,652
+4,561
| +19% | +$306K | 0.09% | 196 |
|
|
2021
Q4 | $1.5M | Buy |
+24,091
| New | +$1.41M | 0.04% | 370 |
|
|
2021
Q3 | – | Sell |
-681,269
| Closed | -$44.9M | – | 2447 |
|
|
2021
Q2 | $45.5M | Buy |
681,269
+662,127
| +3,459% | +$43.2M | 1.42% | 6 |
|
|
2021
Q1 | $1.21M | Buy |
19,142
+2,357
| +14% | +$147K | 0.06% | 280 |
|
|
2020
Q4 | $1.04M | Sell |
16,785
-16,975
| -50% | -$1.04M | 0.03% | 415 |
|
|
2020
Q3 | $2.04M | Buy |
+33,760
| New | +$2.03M | 0.1% | 156 |
|
|
2020
Q2 | – | Sell |
-24,886
| Closed | -$1.49M | – | 1697 |
|
|
2020
Q1 | $1.39M | Sell |
24,886
-4,459,223
| -99% | -$273M | 0.09% | 176 |
|
|
2019
Q4 | $288M | Buy |
+4,484,109
| New | +$257M | 15.77% | 1 |
|
|
2019
Q1 | – | Sell |
-118,285
| Closed | -$5.89M | – | 1112 |
|
|
2018
Q4 | $6.15M | Buy |
+118,285
| New | +$6.36M | 0.39% | 55 |
|
|
2017
Q1 | – | Sell |
-137,270
| Closed | -$7.53M | – | 1054 |
|
|
2016
Q4 | $8.02M | Sell |
137,270
-173,756
| -56% | -$9.5M | 0.4% | 48 |
|
|
2016
Q3 | $16.8M | Buy |
+311,026
| New | +$20M | 0.59% | 18 |
|
|
2015
Q2 | – | Sell |
-112,091
| Closed | -$7.39M | – | 993 |
|
|
2015
Q1 | $7.23M | Sell |
112,091
-41,663
| -27% | -$2.61M | 0.49% | 45 |
|
|
2014
Q4 | $9.08M | Buy |
+153,754
| New | +$8.67M | 0.34% | 66 |
|
|
2014
Q3 | – | Sell |
-10,459
| Closed | -$507K | – | 1011 |
|
|
2014
Q2 | $507K | Buy |
+10,459
| New | +$515K | 0.02% | 442 |
|
|
2014
Q1 | – | Sell |
-26,039
| Closed | -$1.39M | – | 1022 |
|
|
2013
Q4 | $1.38M | Buy |
+26,039
| New | +$1.33M | 0.04% | 349 |
|
|
2013
Q3 | – | Sell |
-119,737
| Closed | -$5.35M | – | 730 |
|
|
2013
Q2 | $5.35M | Buy |
+119,737
| New | +$5.2M | 0.18% | 120 |
|
Other funds holding BMY
HAP Trading's BMY Position: Q3 2024 in Review
HAP Trading sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 32,509 shares — an estimated $1.53M sold.
HAP Trading first reported a position in BMY in Q2 2013 and held it in 22 quarters. The position peaked at $288M in Q4 2019. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- HAP Trading reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
- HAP Trading sold 32,509 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.53M.
- HAP Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 22 quarters.
- HAP Trading's Bristol-Myers Squibb position peaked at $288M in Q4 2019.
- 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on HAP Trading's 13F filing for Q3 2024, filed 12 Nov 2024.